Active	Status	Sponsor type	Region	Phase	Filter
2 Active 3 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ritchie, Ellen K
NCT03335267: Investigator Initiated Trial of CPX-351 for Untreated Acute Myeloid Leukemia	Completed	2	30	US	CPX-351	Weill Medical College of Cornell University, Jazz Pharmaceuticals	Leukemia, Myeloid, Acute	12/18	05/20
CPX GO, NCT03878927: CPX-351+GO in Subjects 55 Years Old, or Older, With AML	Terminated	1	11	US	CPX-351, Vyxeos, Gemtuzumab Ozogamicin, Mylotarg	Weill Medical College of Cornell University, Jazz Pharmaceuticals, Pfizer	Acute Myeloid Leukemia	08/22	09/22